Sponsor Pipeline

Toll Biotech Co. Ltd. (Beijing) Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
1
Recruiting
2
Disease Areas
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-08-04 NCT07745725 A Phase II Study of TollB-001 Tablets in Systemic Sclerosis Phase 2 Not Yet Recruiting
Active Trials by Phase
Phase 2
2
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07408024 Safety and Efficacy of TollB-001 Tablets in Moderate to Severe Rheumatoid Arthritis Rheumatoid Arthritis (RA) Recruiting
NCT07745725 A Phase II Study of TollB-001 Tablets in Systemic Sclerosis Systemic Sclerosis (SSc) Not Yet Recruiting
Disease Areas
Rheumatoid Arthritis (1) Scleroderma (1)
Get alerts when Toll Biotech Co. Ltd. (Beijing)'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free